Kancera is Biotechnology in Sweden that focus on severe viral infections business. They cover business area such as Kancera AB, drug, damage, acute and chronic inflammation, hyperinflamation, various disease state, vital organ, conjunction, myocardial infarction, severe viral infection, two phase ii clinical trial, cardiac patient, research, development, Stockholm.
-
Severe Viral Infections
-
Karolinska Institutet Science Park
Banvaktsvägen 22
171 48 Solna
Sweden
Private
Kancera ABdrugdamageacute and chronic inflammationhyperinflamationvarious disease statevital organconjunctionmyocardial infarctionsevere viral infectiontwo phase ii clinical trialcardiac patientresearchdevelopmentStockholm
* We use standard office opening hours in near Kancera's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kancera is Biotechnology business from Sweden that founded in - ( years old in ), Kancera business is focusing on Severe Viral Infections.
Kancera headquarter office and corporate office address is located in Karolinska Institutet Science Park Banvaktsvägen 22 171 48 Solna Sweden.
Kancera was founded in Sweden.
In , Kancera is currently focus on severe viral infections sector.
Above is snippet of Google Trends for "severe viral infections" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kancera, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
